好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Which Is the Best Indication to Early Treat with Interferon [beta] the Clinically Isolated Syndromes Based on the Clinical Onset? A Cochrane Metanalysis
MS and Related Diseases
(-)
146
Authors/Disclosures
Marinella Clerico, MD (University of Torino) Dr. Clerico has nothing to disclose.
No disclosure on file
No disclosure on file
Jacqueline Palace (John Radcliff Hospital Oxford Univeristy Hospitals Trust) Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono, Medimmune, Argenx, Janssen, AMgen, UCB, Roche, Novartis, Amplo, Alexion, . Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx, Sanofi. Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche, UCB, Alexion, Amgen. Dr. Palace has or had stock in Astra Zenica. The institution of Dr. Palace has received research support from Roche, AMPLO, Alexion, UCB,. argenx, amgen. Dr. Palace has received intellectual property interests from a discovery or technology relating to health care.
Maria Tintore-Subirana, MD No disclosure on file
Luca Durelli, MD (Divisione Universitaria di Neurologia) No disclosure on file